유전자 편집 완벽 가이드.
메뉴
배우기 뉴스 아틀라스에 질문하기
둘러보기 기술들 질환 치료법들 임상시험 기업 과학자들 유전자 연구 기관
의학을 넘어서 농업 윤리 투자 세계 지도
배우기 & 도구 여기서 시작하세요 용어집 A–Z 기술 비교 타임라인 목록 & 순위 AI 에이전트 ★ 저장됨 API
소개 소개 방법론 데이터 출처 편집 방침 문의 면책 조항

🧭 안내 보기
유전학이 처음이신가요? 둘러보시는 동안 모든 용어를 쉬운 말로 설명해 드립니다. 도움말이 내장된 동일한 페이지입니다.

⚡ 전문가 견해
생물학은 이미 알고 계시죠. 내용만 — 깔끔하고 간결하게, 추가 설명 없이. 기본 보기입니다.

인터페이스 언어
라이트 모드

윤리 · Human editing

Human embryo research

Editing embryos in the laboratory, without transfer to a uterus, is permitted in some countries and prohibited in others — and it is how the risks of germline editing are actually studied.

How this page is written The Atlas does not take a position on contested ethical questions. Each page sets out the strongest version of the arguments on each side, states what is scientifically settled and what is not, and summarises the law where it exists. Where we think a claim is factually wrong — as opposed to ethically contested — we say so and cite the evidence.

핵심 질문

There is a difference between editing an embryo to learn something and editing one to make a baby. The first happens in laboratories under licence in several countries, with embryos destroyed after a limited period and never transferred to a uterus. It is also how researchers discovered that embryo editing is far messier than expected — knowledge that is a central argument against ever doing it reproductively.

Research editing of human embryos without transfer is regulated distinctly from reproductive use. The UK permits it under HFEA licence within the 14-day limit; several countries permit it under national frameworks; others prohibit it entirely. Research has revealed high rates of mosaicism, large on-target deletions and loss of heterozygosity following editing in embryos — findings that materially strengthen the safety case against reproductive use, and that could not have been obtained any other way.

The arguments

지지자들의 주장
  • It is the only way to understand early human development and why so many pregnancies fail.
  • It generates precisely the safety data needed to evaluate germline claims, rather than speculating.
  • Strict licensing with a firm limit and no transfer is a workable and long-established framework.
  • Model organisms diverge from humans at exactly the developmental stages that matter most.
비판론자들의 주장
  • Some hold that an embryo has moral status making research use impermissible regardless of benefit.
  • Permitting research use may make reproductive use more likely over time.
  • The 14-day limit was a pragmatic convention rather than a principled boundary, and pressure to extend it is now real.

Where the science actually stands

Research editing without transfer is legal under licence in several countries and prohibited in others; positions follow national law and values rather than scientific disagreement. The research itself has produced findings — mosaicism, large deletions, loss of heterozygosity — that are central to why reproductive germline editing is not considered safe.

Law and regulation

관할 지역위치도구
United Kingdom Permitted under HFEA licence up to 14 days; transfer to a uterus prohibited Human Fertilisation and Embryology Act
United States No federal funding for research destroying embryos; privately funded research permitted in some states Dickey-Wicker Amendment; state law
Germany Highly restricted Embryonenschutzgesetz
Japan Permitted for research under guidelines; reproductive use prohibited National guidelines

법률 자문이 아닌 개요 안내용으로 요약된 내용입니다. 법률은 변경될 수 있으며 국가별 시행 방식도 다릅니다. 해당 관할권의 현행 법률을 반드시 확인하세요.

Unresolved questions

  • Whether the 14-day limit should be revised now that culture beyond it is technically possible.
  • How to fund and oversee research that many citizens object to on principle.

Sources